ArticlebioRxiv : the preprint server for biology2026
Integrative modeling of read depth and B-allele frequency improves single-cell copy number calling from targeted DNA sequencing panels.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
4 authors.
Funding
Abstract
Copy number variations (CNVs) drive cancer initiation and progression, but resolving them at single-cell resolution from targeted DNA sequencing panels remains challenging. The Mission Bio Tapestri platform generates two complementary signals for CNV inference: sequencing depth and B-allele frequency (BAF) from heterozygous variants; however, existing methods such as karyotapR rely primarily on read depth, potentially missing allele-specific events invisible to depth-only approaches. Here we introduce scPloidyR, a hidden Markov model (HMM) that jointly models read depth and BAF at amplicon resolution for single-cell copy number calling from Tapestri data. scPloidyR fits independent per-chromosome Markov chains with copy number states as hidden variables, factorizes emission probabilities into depth and BAF likelihoods, and learns parameters via Baum-Welch expectation-maximization with Viterbi decoding. We compared scPloidyR with the established karyotapR Gaussian Mixture Model (GMM) through two simulation studies that evaluates BAF noise, variant density, amplicon density, sample size, and heterozygosity rate, and through application to a public Tapestri five-cell-line mixture dataset. In simulations, scPloidyR substantially outperformed karyotapR on class-balanced metrics (macro-F1: 0.472 vs. 0.264; alteration F1: 0.902 vs. 0.383 in simulation study 1) when allelic information was available. Adding just one heterozygous variant per amplicon increased scPloidyR accuracy from 0.548 to 0.899 for copy number gains. However, when BAF information was absent, karyotapR outperformed scPloidyR, and high BAF noise substantially degraded joint-model performance. On real data, scPloidyR produced more spatially coherent and biologically plausible copy number profiles. These results establish that joint depth-BAF modeling provides a clear advantage for single-cell CNV calling when allelic information is available, while depth-only methods remain preferable when such information is absent.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.